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Abstract
Molecular studies of bacterial virulence are enhanced by expression of recombinant DNA during infection to allow
complementation of mutants and expression of reporter proteins in vivo. For highly pathogenic bacteria, such as Yersinia
pestis, these studies are currently limited because deliberate introduction of antibiotic resistance is restricted to those few
which are not human treatment options. In this work, we report the development of alternatives to antibiotics as tools for
host-pathogen research during Yersinia pestis infections focusing on the diaminopimelic acid (DAP) pathway, a requirement
for cell wall synthesis in eubacteria. We generated a mutation in the dapA-nlpB(dapX) operon of Yersinia pestis KIM D27 and
CO92 which eliminated the expression of both genes. The resulting strains were auxotrophic for diaminopimelic acid and
this phenotype was complemented in trans by expressing dapA in single and multi-copy. In vivo, we found that plasmids
derived from the p15a replicon were cured without selection, while selection for DAP enhanced stability without detectable
loss of any of the three resident virulence plasmids. The dapAX mutation rendered Y. pestis avirulent in mouse models of
bubonic and septicemic plague which could be complemented when dapAX was inserted in single or multi-copy, restoring
development of disease that was indistinguishable from the wild type parent strain. We further identified a high level,
constitutive promoter in Y. pestis that could be used to drive expression of fluorescent reporters in dapAX strains that had
minimal impact to virulence in mouse models while enabling sensitive detection of bacteria during infection. Thus,
diaminopimelic acid selection for single or multi-copy genetic systems in Yersinia pestis offers an improved alternative to
antibiotics for in vivo studies that causes minimal disruption to virulence.
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Introduction
Yersinia pestis is the causative agent of plague and is a recently
evolved pathogen [1,2]. Due to its ability to undergo genetic flux
from loss of genetic content and acquisition of DNA by horizontal
transfer, Y. pestis evolved from a mild gastro-instestinal pathogen to
one that rapidly induces high titer sepsis in mammals in order to
promote its transmission and environmental survival in fleas [3].
Many biovars of Y. pestis exist, varying between one another by
significant changes including plasmid acquisition, while even
within biovars, strains differ due to numerous point mutations,
often in non-coding sequences [4,5]. Isolation of multi-antibiotic
resistant Y. pestis from human plague patients has been reported in
two independent cases, both of which were due to the acquisition
of different multi-drug resistant plasmids highlighting a potential
public health concern for the evolution of drug resistant plague
[6,7,8]. This, combined with its hypervirulence in humans and
mammals, stable maintenance in the environment between
outbreaks, and the potential for rapid spread among humans,
makes Yersinia pestis a potential reemerging threat to public health.
Heightened concern over highly pathogenic microbes such as
Yersinia pestis has led to a surge in plague investigations, from basic
mechanisms of pathogenesis to the development of novel vaccines
and therapeutics. Yet, currently available gene expression and
gene knockout tools used for attenuated Yersinia strains rely on the
introduction of antibiotic resistance which is restricted in the
virulent isolates, thereby limiting the potential output of this surge
in research activity. In this work, we addressed this shortfall and
report the adaptation of standard genetic tools for metabolic rather
than antibiotic selection.
Biosynthesis of lysine has become an increasingly used anti-
bacterial target as it provides essential protein (lysine) and cell wall
(meso-diaminopimelic acid) components, thereby inhibiting bac-
terial growth by two mechanisms [9]. Mammals are unable to
synthesize lysine and lack diaminopimelic acid, therefore the
presence of a functional lysine biosynthetic pathway is essential for
bacterial growth in mammalian hosts. Like antibiotics, this
property has been explored as a mechanism for selection of
bacteria carrying recombinant plasmids during infection. For
example, Salmonella typhimurium lacking asdA (aspartate dehydroge-
nase) is unable to synthesize diaminopimelic acid and therefore is
avirulent in a mouse model of disease [10,11]. Growth of this
mutant is dependent on exogenous diaminopimelic acid or on the
plasmid expression of asdA allowing for its selection in vivo.I nE.
coli, deletion of dapA, B, C, D and E confer diaminopimelic acid
auxotrophy that can be used to select for recombinant DNA [12].
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have been reported for other Gram negative pathogens such as
Burkholderia pseudomallei, thus it appears there are multiple genetic
targets to block this highly conserved metabolic pathway [13,14].
In this work, we explored the utility of diaminopimelic acid
selection in Yersinia pestis for single and multi-copy expression of
recombinant DNA. In Y. pestis, the genes encoding dapB, C, D and E
are duplicated with two copies of each present in the chromosome
[15]. However the gene encoding dapA, a dihydropicolinic acid
synthetase, is present in another chromosomal location, found in
single copy, and is therefore predicted to be necessary for an early
step of the pathway for biosynthesis of diaminopimelic acid. In Y.
pestis, as well as many other bacteria, dapA is annotated as the first
gene of an operon that includes nlpB/dapX, an outer membrane
lipoprotein that is not essential for growth [16]. Here we show that
null mutation of the dapAX operon results in diaminopimelic acid
(DAP) dependent growth and an avirulent phenotype in mouse
models of plague. Growth without DAP could be restored by
supplying Y. pestis dapA in single or multiple copies and retention of
plasmids could be achieved in vivo during murine infection.
Complementation of the dapAX mutation in vivo required the
introduction of both genes in trans, either in single or multiple copy,
and this restored the development of plague to near wild type levels.
We used this system to generate a sensitive DAP-selectable
fluorescent expression system that enables identification of bacteria
during infection. Together the data demonstrate the utility of the
diaminopimelic acid biosynthetic pathway as an improved alterna-
tive to antibiotic selection for expression of recombinant DNA
during experimental models of plague.
Materials and Methods
Bacterial strains and growth conditions
Y. pestis strains used in this study are listed in Table 1 and E. coli
strains are listed in Supplemental Table S1. All strains used were
taken from frozen stocks and streaked for isolation onto heart
infusion agar (HIA) plates. The plates used for Y. pestis CO92 were
supplemented with 0.005% Congo Red and 0.2% galactose to
identify bacteria that retain the pigmentation locus [17]. For
bubonic plague challenge, a single red pigmented colony was used
to inoculate heart infusion broth (HIB) and grown 18–24 hrs at
26uC, 120 rpm. All handling of samples containing live Y. pestis
CO92 was performed in a select agent authorized BSL3 facility
under protocols approved by the University of Missouri Institu-
tional Biosafety Committee. Y. pestis KIM D27, a non-pigmented
strain originally isolated by Robert Brubaker, was routinely grown
fresh from frozen stock on HIA, followed by aerobic growth at
26uC in HIB overnight prior to use in experiments [18]. Where
indicated, ampicillin (100 mg/ml) was added to media for selection
of plasmids. For growth of dapA mutant Y. pestis, 400 mg/ml
diaminopimelic acid (DAP) (Sigma Aldrich, St Louis, MO) was
added to liquid or agar media.
E. coli DH5a and JM109 served as cloning strains for
construction of recombinant pACYC177 and pBR322 (New
England Biolabs, Ipswich, MA) based plasmids [19,20]. E. coli
S17-1lpir [21] served as cloning strain for Ori-R6K based
plasmids, including the suicide vector and the mini-Tn7 vectors
[22,23]. E. coli strains were grown in LB media for propagation.
For cloning purposes, ampicillin (100 mg/ml) was added to the
media for selection.
Plasmids and dapAX complementation
Plasmids and primers used or developed in this study are listed
in Supporting Information, Tables S1, S2 and S3. Yersinia pestis
dapA and dapAX were amplified from Y. pestis KIM D27 by PCR.
pACYC177 was modified by replacement of the kanamycin
resistance gene with that of dapA and its endogenous promoter
using restriction sites HindIII and SmaI. The resulting plasmid no
longer conferred kanamycin resistance but still retained ampicillin
resistance and was used for complementation studies. The suicide
vector, pCVD442 dapA, was constructed by amplifying 1,000 bp
upstream of the dapA promoter and 1,000 bp downstream of the
dapA stop codon [22,24]. These DNA fragments were amplified by
PCR and ligated into the XbaI and SphI sites of pCVD442 using
EcoRI as a linker between upstream and downstream DNA
segments. Restriction enzymes and T4 DNA ligase were
purchased from New England Biolabs (Ipswich, MA). Promoter-
less DsRed was amplified from pDsRed Monomer (Clontech,
Mountain View, CA) and cloned into pBR322 for use in the
promoter trap screen. For Tn7 transposition, dapA or dapAX was
Table 1. Bacterial strains used in this study.
Y. pestis Strains Key Properties Reference
KIM D27 Pgm
- Lcr
+; KIM 5 derivative [18]
KIMD27-1003 KIM D27; Missing dapA promoter and entire dapA ORF, generated with pCVD442-dapAX This Study
KIMD27-1011 KIM D27dapAXattTn7::dapA; dapA transposition downstream of glmS of the KIMD27-1003 parent strain This Study
KIMD27-1012 KIM D27dapAXattTn7::dapAX; dapAX transposition into the attTn7 site of the KIMD27-1003 parent strain This Study
KIMD27-1013 KIM D27dapAXattTn7::dapAX DsRed; dapAX and cysZ-DsRed transposition into the attTn7 site of the
KIMD27-1003 parent
This Study






CO92-1008 CO92; Missing dapA promoter and entire dapA ORF, generated with pCVD442-dapAX This Study
CO92-1009 CO92dapAXattTn7::dapAX; dapAX transposition into the attTn7 site of the CO92-1008 parent strain This Study
CO92-1010 CO92dapAXattTn7::dapAX DsRed; dapAX and cysZ-DsRed transposition into the attTn7 site of the
CO92-1008 parent strain
This Study
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pUC18R6KT mini-Tn7 [23].
Animals
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health and was
approved by the Animal Care and Use Committee of the
University of Missouri. All efforts were made to minimize suffering
of the animals. Male and female BALB/c or C57BL/6 mice, 6–8
weeks old, were either purchased from Charles River Laboratories
(Wilmington, MA) or were bred and raised in barrier facilities at
the University of Missouri. During bubonic plague challenge, mice
were maintained in select agent approved containment facilities at
the University of Missouri. All infected mice were monitored
regularly by daily weighing and assignment of health scores.
Animals that survived to the end of the 14 day observation period
or were identified as moribund (defined by severe ataxia) were
euthanized by CO2 asphyxiation followed by bilateral pneumo-
thorax, methods approved by the American Veterinary Medical
Association Guidelines on Euthanasia.
Plague challenge
For bubonic plague, Y. pestis CO92, grown as described above,
was diluted in sterile PBS to the indicated dose just prior to use for
challenge experiments. Bacteria were delivered in 100 ml volume
by subcutaneous injection in BALB/c mice (LD50=1 CFU) [25].
Actual dose and retention of the pigmentation locus were
determined by plating in triplicate on HIA with congo red. For
intravenous challenge involving non-pigmented Y. pestis KIM D27,
bacteria were diluted in sterile PBS and delivered by tail vein
injection of 100 ml (LD50=100 CFU) into BALB/c or C57BL/6
mice [26]. For intranasal challenge involving non-pigmented Y.
pestis KIM D27, 20 ml of bacteria grown and diluted as described
above, was delivered to BALB/c mice that were pre-treated by
intraperitoneal injection of 500 mgF e
+2 (FeCl2). All animals
subcutaneously or intranasally infected with Y. pestis were first
lightly anesthetized by isoflurane inhalation. Animals were
observed for recovery from anesthesia following the procedure
and returned to housing. LD50 determination was performed by
the method of Reed and Muench [27].
Competitive Index
This method was performed as previously described [28]. Wild
type Y. pestis KIM D27 with or without recombinant pACYCdapA
were combined in a 1:1 ratio (doses ranging from 1,000 to
13,000 CFU each strain) and injected intravenously into BALB/c
or C57BL/6 mice in a 100 ml volume. Four days post infection,
mice were euthanized, and spleens were harvested, homogenized
in PBS and plated in duplicate on HIA (all bacteria) and HIA +
amp (plasmid-bearing bacteria). To calculate plasmid loss,
bacterial colony forming units (CFU) recovered without amp
selection were subtracted from the CFU recovered with amp
selection and percentages of each found in the spleen were
determined. The Competitive Index (C.I.) is defined as: % amp
r
recovered/% amp
r input. For statistical analysis, the proportions
of amp
r to total CFU recovered was compared with the ratio of
amp
r to total CFU in the inoculum.
Yersinia promoter trap screen
Primers with abutted restriction sites were used to amplify the
open reading frame of DsRed-Monomer (Clontech, Mountain
View, CA) which was subsequently ligated into pBR322 (New
England Biolabs, Ipswich, MA) in place of the tetracycline
resistance gene. Y. pestis KIM D27 genomic DNA was digested
with RsaI and 100–1,50 bp DNA fragments were ligated directly
upstream of DsRed. Colonies were screened in E. coli DH5a for
DsRed expression, and those that gave the strongest signal were
transformed into Y. pestis KIM D27 and checked for DsRed
fluorescence. One plasmid from this screen, pRsaI-2.1, was further
characterized by sequence analysis, and then sub-cloned into
pDB2 (pUC18R6KT + dapAX). The resulting plasmid was then
used for transposition into Y. pestis KIM D27- 1003 (dapAX)t o
insert DsRed and dapAX into the chromosome. The cysZK
promoter-containing fragment was amplified from Y. pestis KIM
D27 with primers which have abutted XhoI and EcoRV sites. The
lac promoter of ptdTomato (Clontech, Mountain View, CA) was
replaced with the cysZK promoter fragment creating pNE160. For
Tn7 transposition, the PcysTomato fragment was digested from
pNE160 with XhoI and EcoRI, and ligated into the XhoI and
EcoRI sites of pDB2.
DsRed expression assay. Single colonies of the indicated strains
were used to inoculate HIB and grown overnight at 26uCo r3 7 uC;
1 mL of culture was removed and pelleted at 6000 rpm for 5
minutes then resuspended in 4% paraformaldahyde and incubated
for 20 minutes. Samples were then washed once and resuspended
in 1 mL PBS. Samples were analyzed on a FluoStar Omega plate
reader for absorbance (600 nm) and DsRed fluorescence (544/
590 nm). Measured fluorescent values were normalized to cell
number.
Macrophage assay
Macrophages were prepared as previously described [29].
Briefly, 1610
6 biotinylated macrophages were plated in DMEM
supplemented with 5% FBS and infected with the indicated strains
at an MOI of 10 for 30 min. Cells were fixed with 4%
paraformaldahyde then stained with DAPI and streptavidin
conjugated to Alexa Fluor 488 (Invitrogen, Carlsbad, CA) and
analyzed by confocal microscopy.
Statistical Analyses
Data from the competitive index were tested for difference from
a given proportion using prop test from R [30]. Briefly, the
proportion of amp
r to total CFU in the recovery was tested for a
difference from the proportion of amp
r to total CFU in the
inoculums using alpha=0.05. Survival data was evaluated by a
modified Gehan-Breslow-Wilcoxon Test [31]. DsRed expression
data were evaluated by one way ANOVA. Significance was
concluded for p,0.05.
Results
Deletion of dapAX in Y. pestis results in DAP auxotrophy
Diaminopimelic acid (DAP) is a component of the cell wall that
provides cross linking of peptidoglycan in many Gram negative
bacteria including Yersinia pestis. Previous work showed that
disruption of the metabolic pathway for biosynthesis of DAP
renders E. coli unable to grow in media lacking diaminopimelic
acid [12]. Thus, standard laboratory media such as heart infusion
agar, blood base agar and Luria agar cannot support growth of
mutants lacking essential genes of the diaminopimelic acid
biosynthetic pathway. A search of the Y. pestis genome revealed
that many genes are duplicated, but one gene required for an
early step in the biosynthetic pathway, dipicolinate synthetase or
dapA, was present in single copy [15]. We therefore generated a
suicide vector designed to delete the promoter and open reading
frame of dapA in Yersinia pestis, which is predicted to delete the
Diaminopimelic Acid Selection in Y. pestis
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operon (Figure 1A). Homologous recombination of the deletion
construct was introduced by pCVD442 into the wild type, non-
pigmented Y. pestis strain KIM D27 and resulted in a mutant
strain that was unable to grow on plates without DAP
supplementation or expression of dapA in trans (Figure 1B, data
not shown). Deletion of dapA was confirmed by PCR, and the
absence of dapA and dapX mRNA was observed by reverse
transcriptase PCR of mRNA purified from stationary phase
cultures (data not shown).
DAP independent growth is restored by expression of dapA in trans.W e
next characterized the Y. pestis KIM D27 dapAX strain for growth
characteristics in laboratory media with and without DAP. The
dapAX strain was unable to grow in broth media without DAP,
either at 26uCo r3 7 uC and this was restored by supplying the wild
type dapA gene in either single or multiple copies (Figure 2).
However, the dapAX mutant grew normally when DAP was added
to the culture media. Following removal of DAP from the media,
viability of the dapAX mutant sharply declined 6 hrs later
indicating depletion of DAP is rapidly lethal to the bacteria (data
not shown). Together the data suggest that the absence of DapA
confers dependency on supplemental diaminopimelic acid for
growth.
We tested for diaminopimelic acid selection during a mouse
model of septicemic plague. In this model, pACYC dapA was
introduced by electroporation into Y. pestis KIM D27-1003 or dapA
was inserted in single copy into the chromosome of the dapAX
mutant using Tn7 transposition, and the resulting strains were
used to infect BALB/c mice by intravenous injection [23,32].
Whereas the dapAX mutant was avirulent, with .10
6 fold increase
in dose required for a lethal infection in this model, both single and
multiple copy complementation with dapA led to substantial, but
not complete, restoration of virulence, with calculated LD50s of
30,409 CFU or 20,804 CFU, respectively, roughly 200–300 fold
Figure 1. Construction of the dapAX mutation results in DAP dependent growth. The dapA promoter and open reading frame were deleted
by homologous recombination using the plasmid pCVD442 (A). Overnight cultures of the indicated strains (the dapAX mutant supplemented with
400 mg/ml DAP) were serially diluted 10 fold in HIB (no DAP) and plated on HIA with or without DAP and incubated at 26uC for 48 hrs (B).
doi:10.1371/journal.pone.0017352.g001
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(Figure 3).
Diaminopimelic acid selection is functional in vivo in
mouse models of plague
To investigate whether or not the dapA plasmid was stably
maintained in vivo, we isolated bacteria from the spleens of BALB/
c mice infected with 20,000 CFU of Y. pestis KIM D27-
1003pACYC-dapA on day 4 post-infection, when each mouse
showed signs of acute disease. Colonies isolated from these spleens
were tested by PCR to verify the presence of all three Y. pestis
virulence plasmids in addition to the plasmid expressing dapA.
PCR analysis of 81 colonies from each mouse verified a high
degree of retention of all three virulence plasmids as no plasmid
loss was seen (Table 2). These results strongly suggest that p15a
plasmids can be selected in vivo without loss of resident Y. pestis
virulence plasmids. However, since the pACYC-dapA strain was
unable to fully restore virulence to wild type levels, we sought to
further characterize the impact of p15a plasmids on the virulence
of wild type Y. pestis.
Diaminopimelic acid selection is necessary for plasmid
retention in vivo
To understand the effects of p15a plasmids on the virulence of Y.
pestis, we performed a competition experiment to determine if
pACYC-dapA impaired growth in vivo. Towards this end, BALB/c
Figure 2. DAP independent growth is restored by expression of
dapA in single or multi copy. Wild type KIM D27, and isogenic strains
KIM D27-1003, KIM D27-1003pdapA, or KIM D27-1011 were grown
overnight in HIB at 26uC, then diluted to an OD600 of .075 and grown
for 25 hrs at 26uC (A) or 37uC (B) with shaking at 130 rpm, monitoring
OD600 as indicated. KIM D27-1003 strain with no DAP supplementation
was washed 3X in sterile PBS to remove excess DAP from the overnight
culture. Data are representative of 3 independent experiments.
doi:10.1371/journal.pone.0017352.g002
Figure 3. Expression of dapA on a multi-copy plasmid partially
restores virulence. Y. pestis KIM D27-1003 (dapAX) either with or
without pdapA (A), or with dapA inserted into the attTn7 site of Y. pestis
KIM D27 (KIM D27-1011) (B) were grown overnight in HIB either with or
without 100 mg/ml ampicillin, then diluted in sterile PBS to the
indicated doses. 100 ml was injected intravenously into the tail vein of
BALB/c mice (n=8 per group for A; n=5 per group for B). Survival was
monitored for 14 days. The observed 50% lethal dose (LD50) was
calculated as 30,409 (pdapA) and 20,804 (KIM D27-1011) by the method
of Reed and Muench [27].
doi:10.1371/journal.pone.0017352.g003





pCD1 lcrH 81/81 100%
yopB 81/81 100%
pPCP1 pla 81/81 100%
pst 81/81 100%
pMT1 caf1 81/81 100%
ymt 81/81 100%
pACYCdapA bla 81/81 100%
doi:10.1371/journal.pone.0017352.t002
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3–
10
4 CFU wild type Y. pestis KIM D27 mixed in a 1:1 ratio with wild
type bacteria expressing pACYC dapA. Following 4 days post-
infection, mice were euthanized and bacteria in the spleens were
enumerated. KIM D27 cells harboring pACYC dapA compared to
those without plasmid were identified by plating bacteria on media
with and without ampicillin. The percentages of plasmid carrying
strain recovered from the spleen were compared to the input values
to calculate the competitive index (CI) (Figure 4). The difference in
proportion between input and recovery between infections in
BALB/c and C57BL/6 mice was then evaluated for statistical
significance. Both strains of mice yielded similar results, and in
nearly all mice, bacteria carrying the plasmid decreased in
proportion after infection (p,0.001) and the corresponding CI
was typically greater than 1 for bacteria without plasmid. Together,
these results suggest that carrying an additional plasmid, though it
may not cause instability of other virulence plasmids, imposes a
biochemical burden that either retards bacterial growth in vivo or
causes it to be subject to curing during the infection.
We therefore also measured stability of pACYC177 and
pACYCdapA during Y. pestis KIM D27 infection of BALB/c mice
without selection. Bacteria harvested from the spleen on day 4
post-infection were monitored for loss of ampicillin resistance by
plating initially on HIA, then patching colonies onto plates with
and without ampicllin. Results showed plasmid loss for both strains
ranging from 1–5% with higher loss for the larger plasmid
containing Y. pestis dapA (Table 3). Together the data indicate that
p15a plasmids are cured during infection and thus may be
incompatible with one or more virulence plasmids.
Single copy complementation of dapAX restores
virulence
Because of the biochemical burden imposed by plasmids, we
tested whether the virulence defect that remains in KIM
D27attTn7::dapA was caused by the lack of dapX/nlpB, a non-
essential gene with no previously known role in virulence. The
dapAX operon was cloned into the multi-cloning site of
pUC18R6KT which is flanked by attTn7 transposition sites. The
resulting plasmid, pDB2, and the helper plasmid encoding the
transposase complex, pTNS2, were electroporated into Y. pestis
KIM D27-1003, and selected on HIA (no DAP). The comple-
mented strain was verified by PCR to carry dapAX downstream of
glmS rather than its original location on the chromosome (data not
shown). To test complementation in vivo, we infected BALB/c mice
with Y. pestis KIM D27dapAX attTn7::dapAX by intravenous
injection and challenged with a dose equivalent to 1 LD50 of
the wild type parent strain. High challenge doses of either wild
type or the dapAX complemented strain resulted in 100% lethality
(data not shown). Moreover, lethality was also similar at low
challenge dose (60% for wild type KIM D27 and 40% for the
single copy dapAX complemented strain) suggesting single copy
expression of dapAX is sufficient to restore virulence to near wild
type levels (Figure 5A).
We also tested whether DAP selection functioned in the fully
virulent Orientalis Y. pestis strain CO92. The dapAX mutation was
generated by deletion of the promoter and open reading frame
for dapA using pCVD442 and homologous recombination as
described above. The resulting strain was unable to grow on
media without supplemental DAP (data not shown). The deletion
was confirmed by PCR as well as retention of all three virulence
plasmids and the pigmentation locus (data not shown). Introduc-
tion of dapAX in single copy using the mini-Tn7 transposon
restored growth in the absence of supplemental DAP. The Y.
pestis CO92 dapAX mutant and dapAX attTn7::dapAX strains were
then used to challenge BALB/c mice by subcutaneous injection
in a bubonic plague model. In this model, insertion of dapAX by
Tn7 transposition also appeared to fully complement virulence
with 100% lethality caused by less than 15 CFU of either wild
type or complemented strain whereas dapA alone did not fully
restore virulence (Figure 5B, unpublished observations) [33].
Histopathology of moribund mice indicated development of
bubonic plague as lymph nodes taken from subcutaneously
challenged mice on day 4 post-infection showed severe hemor-
rhage and necrosis similar to wild type (Figure 6). Thus, with
DAP as a selection for Tn7 insertion of genes in single copy,
virulence could be restored indicating no significant impact on
pathogenesis.
Figure 4. pACYC177 imposes a biochemical burden on Y. pestis
in vivo. Y. pestis KIM D27 with or without pdapA was grown overnight
in HIB with or without, respectively, ampicillin. An approximately 1:1
ratio of each strain was mixed and delivered by intravenous injection
into the tail vein of BALB/c (A) or C57BL/6 (B) mice. On day 4 post-
infection, when many of the mice were moribund, spleens were
harvested and bacterial titer was determined for strains with and
without plasmid by plating serial dilutions on HIA and HIA+amp. The
Competitive Index (C.I.) is defined as the ratio of recovered bacteria
from mouse spleens divided by the ratio in the inoculum. Scores less
than one indicate the plasmid-bearing strain was less fit than its
counterpart within an individual mouse. After no significant difference
between experiments were detected, data were pooled from 3
independent experiments with groups of 4–5 mice, and a total of 15
(BALB/c) and 13 (C57BL/6), respectively, were analyzed. Data were
tested for difference of proportion using R giving p,0.0001.
doi:10.1371/journal.pone.0017352.g004
Table 3. p15a plasmid loss with no selection detected in





S CFU Plasmid Loss
b
1- pdapA 100 5 5%
2- pdapA 100 2 2%
3- pdapA 80 3 3.75%
Combined 280 10 3.5%
1- pACYC-177 100 1 1%
2- pACYC-177 60 1 1.66%
3- pACYC-177 97 1 1.03%
Combined 257 3 1.17%
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fluorescence in vivo
To exploit DAP selection for virulence studies, we screened for
constitutively active Yersinia promoters that could drive high level
expression of the fluorescent protein DsRed permitting detection
by confocal microscopy in single copy. Towards this end, a library
of Y. pestis KIM D27 DNA fragments (100–1,500 bp) fused to a
promoterless DsRed plasmid was generated in E. coli. Colonies
were screened for expression of DsRed and those with the
strongest signal were then tested for activity in Y. pestis. The
strongest isolate, RsaI-2.1, could be identified on agar media as a
red colony in both E. coli and Yersinia (data not shown). The insert
was characterized by sequencing, revealing the presence of the
cysZK promoter and first 178 codons of its open reading frame
fused in frame to DsRed. We then cloned this cysZK promoter
element from Y. pestis and generated Tn7 constructs for the red
fluorescing proteins DsRed and tdTomato.
Pcys-DsRed and Pcys-Tomato reporters were introduced into Y.
pestis CO92dapAX by Tn7 transposition and selected by growth on
HIA without DAP supplementation. The resulting strains were
confirmed by PCR (data not shown) and expression of DsRed or
Tomato was monitored in overnight cultures incubated at 26uCo r
37uC in HIB. The results showed strong expression of DsRed, and
even stronger red fluorescence was observed in the strain
expressing Tomato (Figure 7). Remarkably, expression of DsRed
or Tomato in this system did not have a significant impact on
virulence compared to complementation with dapAX alone in an
Figure 5. Complementation of the dapAX operon by chromo-
somal insertion restores virulence. (A) Y. pestis KIM D27 and KIM
D27-1012 (dapAX attTn7::dapAX) were grown overnight, diluted to the
indicated dose in sterile PBS and delivered by intravenous injection into
the tail vein of BALB/c mice. (B) Y. pestis CO92, CO92-1008 (dapAX), and
CO92-1009 (dapAX attTn7::dapAX) were grown overnight, diluted to the
indicated dose in sterile PBS and delivered by subcutaneous injection
into the left hind limb of BALB/c mice (n=5 for all groups). Survival was
monitored over 14 days for both models. No significant difference in
survival was detected between wild type and dapAX complemented
strains (p=0.22 for KIM D27; p=0.10 for CO92) using the Gehan-
Breslow-Wilcoxon test.
doi:10.1371/journal.pone.0017352.g005
Figure 6. Development of fulminant bubonic plague is
restored by attTn7::dapAX. Y. pestis CO92 and CO92-1009 (dapAX
attTn7::dapAX) were grown overnight at 26uC, diluted in sterile PBS to
the indicated doses and delivered to BALB/c mice by subcutaneous
injection. On day 4 post-infection, the left inguinal lymph node was
removed, fixed in formalin, sectioned and stained with hematoxylin and
eosin (H&E). (A–B) Uninfected; (C–D) CO92; (E–F) CO92-1009. Images are
representative of tissues harvested from 5 mice in each group.
doi:10.1371/journal.pone.0017352.g006
Figure 7. The cysZK promoter supports high level expression of
fluorescence in single copy in Y. pestis. Y. pestis CO92 strains were
grown overnight in HIB at 26uC (open bars) or 37uC (closed bars) and
then analyzed on a 96-well plate. Relative fluorescent units (RFU) were
measured on a plate reader at an excitation/emission spectra of 544/
590 nm. Each value was normalized to the OD600 of the sample. To
facilitate removal from the BSL-3 laboratory, 1 mL of culture was
removed, fixed in 4% paraformaldahyde then resuspended in PBS. Error
bars represent the standard error of the mean between three distinct
overnight cultures.
doi:10.1371/journal.pone.0017352.g007
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approximately 50X LD50 caused similar lethality (Table 4) [34].
Likewise, expression of DsRed or Tomato in fully virulent Y. pestis
CO92 caused lethality similar as wild type when challenged with
50X LD50 in a bubonic plague model.
Next, we tested fluorescence expression during macrophage
infections. Y. pestis KIM D27pRsaI-2.1 (multi-copy DsRed), KIM
D27-1013 (single copy DsRed) or KIM D27-1014 (single copy
Tomato) were grown at 26uC overnight, diluted in sterile PBS and
added to biotin labeled RAW 264.7 macrophage-like cells.
Infection was initiated by centrifugation, and after 30 min, cells
were fixed and labeled with streptavidin-Alexa Fluor 488 to enable
fluorescent detection of macrophages, then examined by confocal
microscopy (Figure 8). Expression of DsRed from this plasmid
could readily be detected after 30 min infection, from both
intracellular and extracellular bacteria, however in single copy
only very dim fluorescence could be seen. Using Tomato,
however, enhanced red fluorescence and was readily visible
compared to the DsRed counterpart even in single copy. Overall,
the cysZK promoter appears to provide very high, constitutive
induction of fluorescence in multiple environments. Together, we
have not only demonstrated the use of diaminopimelic acid as a
flexible selection system for in vitro and in vivo studies of Yersinia
pestis, but we have developed reagents that facilitate pathogenesis
research using state-of-the-art technology.
Discussion
Research on highly pathogenic organisms such as Yersinia pestis
has inherent limitations because of biosafety precautions and
those required of genetic engineering. In particular, selection of
recombinant DNA, either for retention of exogenous plasmids or
to identify recombination events must be restricted to avoid the
creation of antibiotic resistant strains that could compromise
human treatment options. In this work we sought to establish a
system for recombinant DNA expression in the highly pathogenic
bacterium Yersinia pestis based on metabolic rather than antibiotic
selection. Our system targets the biosynthesis of the cell wall,
similar to commonly used antibiotics that are effective against Y.
pestis. Introduction of a null mutation in the dapAX operon caused
growth dependence on diaminopimelic acid (DAP) for assembly
of a functional cell wall. The resulting strain was highly
attenuated for virulence in mouse models, and predictably will
be in all mammalian hosts as well as the flea vector, none of
which harbor pools of DAP. Importantly, no spontaneous
reversion to DAP-independent growth was seen either in vitro or
Table 4. High level, constitutive expression of DsRed or
Tomato causes minimal disruption to virulence.
Strain Percent Survival Challenge Dose
KIM D27 16.7 (1/6) 5.6610
5a






CO92 0 (0/8) 58
b
CO92 -1010 (dapAX attTn7::DsRed) 12.5 (1/8) 66
b
CO92-1011 (dapAX attTn7::Tomato) 12.5 (1/8) 60
b
a: Challenge by intranasal instillation; mice pre-treated with 500 mgF e
+2 just
prior to challenge; dose is equivalent to 50X LD50 for wild type KIM D27.
b: Challenge by subcutaneous injection; dose is equivalent to 50X LD50 for wild
type CO92.
doi:10.1371/journal.pone.0017352.t004
Figure 8. Detection of intracellular and extracellular bacteria by microscopy of single copy expression of PcysTomato. (A–B) Y. pestis
KIM D27, (C–D) pRsaI-2.1, (E–F) KIM D27-1013 (dapAX attTn7::dapAX PcysDsRed), or (G–H) KIM D27-1014 (attTn7::dapAX cys-Tomato) were grown
overnight in HIB at 26uC, diluted 1:15 in HIB and grown for 2 hours, and then used to infect biotinylated RAW 264.7 macrophage-like cells at an MOI
of 10 for 30 minutes. Cells were then fixed and stained with streptavidin conjugated to AlexaFluor 488 to indentify the host cell membrane. Samples
were analyzed by laser scanning confocal microscopy.
doi:10.1371/journal.pone.0017352.g008
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pestis research.
Unfortunately, the DAP selection system requires working in a
mutant strain background which precludes its use on pre-existing
strains. However, the benefits of switching to this approach are not
limited to the ability to conduct experiments in a safer genetic
background. Antibiotic selection in the mammalian or vector host
is at best cumbersome, with a requirement for daily or more
administration of drug, which may impact the outcome of
infection. This introduces experimental risk, including safety
concerns, reproducibility of dosing and other, perhaps unpredicted
effects on the bacterium or host causing inherent variability and
complications with interpretation. Thus, metabolic selection is
superior to the introduction of antibiotic resistance for experi-
mental models of infectious diseases.
The DAP system permits in vivo selection of plasmids, enabling
the faithful study of gene expression by multi-copy plasmids, which
has previously not been achieved for Y. pestis. To facilitate these
studies, we generated dapAX mutant strains in multiple Y. pestis
backgrounds for use in all in vivo model systems, including both
mammals and fleas (Table S3). Moreover, in this work, we found
that both genes in the dapAX operon contributed to virulence of Y.
pestis in mouse models of bubonic and septicemic plague, thereby
reducing the potential for spontaneous reversion of virulence.
Because of its specific role in virulence, we were able to
demonstrate complementation of lethality by expressing dapX in
trans, showing proof of concept for our system.
We reported the identification of a strong, likely constitutively
active Y. pestis promoter, with similar activity in E. coli, that can
drive detectable expression of a fluorescent reporter protein in
laboratory media or during macrophage infection. cysZ is a
conserved, non-essential gene that encodes an inner membrane
protein involved in sulfate transport [35,36]. It is not surprising
that sulfate transporter proteins would be highly abundant as this
is a key nutrient for cells during all phases of growth. Other
metabolite transporter genes have been used in expression vector
systems, such as the lac operon. Though we and others have
employed lac promoter constructs for high level expression of
recombinant protein in Y. pestis, these promoter systems have not
been strong enough for single copy use (Eisele, Keleher and
Anderson, unpublished observations). Our screen identified
optimized production of DsRed and tdTomato under conditions
that minimized any impact to bacterial growth. Moreover, because
cysZ is conserved in other Gram negative bacteria, it is likely that
this technology may be broadly useful for pathogenesis research.
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